Market Watch

Glenmark Pharmaceuticals Ltd.

AS ON 13 15 PM | 13 201
AS ON 13 16 PM | 13 201
NSE
BSE
339.60-2.00-0.59%
Today's Trend
Low
267.25
High
705.90
Volume
1211329.00
Open
343.65
Prev Close
341.60
339.70-1.65-0.48%
Today's Trend
Low
267.30
High
706.90
Volume
72257.00
Open
345.60
Prev Close
341.35
x
Add to Portfolio
Add to Watchlist

Technical Chart

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
Bid
Offer

Mkt Cap (₹ Cr.)

9585.25
9585.25

Face Value (₹)

1.00
1.00
P/E (x)
14.91
14.91
EPS-TTM(₹)
22.78
22.78
P/B (x)
1.71
1.71
BV/Sh(x)
198.63
198.63
Div. Yield(%)
0.59
0.59
52Wk L/H
267.25
705.90
267.30
706.90


News & Recos

MORE FROM NEWS & RECOS
Glenmark Pharmaceuticals Ltd. share price
down -0.59%
down -0.48%
from its previous close of Rs
341.60
341.35
. Glenmark Pharmaceuticals Ltd. stock last traded price is
339.60
339.70
Glenmark Pharmaceuticals Ltd. Share Price
Value
Today/Current/Last
339.60
339.70
Previous Day
341.60
341.35

Earnings
(Figures in Rs. Cr.)

Sales

Other Operating
Income

Operating Profit

Other Income

EBITDA

Interest

Depreciation

Tax

Net Profit

EPS (₹)

Sep 2019
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
2,763.73
21.02
8.81
0.00
8123.35
51.31
30.64
23.71
0.00
174.16
450.41
31.73
2.34
-62.92
2640.87
80.83
4742.72
-42.22
-1.24
200.85
531.23
54.62
-8.41
-62.92
2640.87
89.77
-3.49
5.46
0.00
116.00
94.16
3.78
14.20
0.00
473.28
91.76
81.51
-44.59
-320.70
266.03
255.54
133.84
-38.27
-127.07
1106.80
9.06
134.11
-38.24
-12.25
66.68

Stock Performance

Period:
LTP
%Change
Trend
339.60
-0.59
526.55
-0.66
462.40
0.12
167.00
2.39
582.80
0.94
340.55
0.68
551.75
0.30
979.55
-0.03
779.85
-1.66
301.60
0.92
1133.05
0.84

Financial Performance

LTP
(₹)
Market Cap
(Cr.)
Price to
Book
Price to
Earnings
PAT
Margins
RoE%
RoA%
Debt to
Equity
Avg. Cost
of Funds%
Current
Ratio
339.60
9638.86420896
1.71975019
15.91367335
9.3700
9.6804
6.9763
0.63750000
1.2100
2.15110000
551.75
10370.26042914
3.81534586
14.85434006
14.8500
14.8356
12.3572
0.18360000
3.3400
1.78490000
582.80
10501.26615225
3.02230649
71.66143137
30.7600
14.2049
15.5859
0E-8
3.1700
5.33040000
979.55
8550.29554095
3.80977894
23.15647151
18.8200
14.2062
14.7786
0.00020000
3.5400
2.82660000
526.55
8442.69677269
1.75559809
20.92158590
6.3000
10.9957
5.0598
0.88220000
1.1600
2.50590000
1133.05
14197.55472779
4.52449788
210.74001377
11.7800
10.8625
10.0408
0.04510000
0.4800
2.28160000
301.60
11954.00000000
3.03647633
56.84530886
18.1600
15.6956
11.0996
0.18370000
0.0000
1.13040000
462.40
6351.35117786
5.43394495
25.75505534
29.6000
14.8666
24.2773
0.00020000
0.0000
1.13000000
779.85
13817.66496057
2.53205336
58.65132204
10.4500
12.2973
8.4420
0.30980000
2.1500
2.77900000
167.00
4273.99482286
14.42775507
-61.22324628
-79.5200
37.4290
-77.3983
0.00360000
0.0000
1.05010000
340.55
3616.38292868
2.31019518
21.52929262
4.0900
6.2903
2.8176
0.16600000
1.2300
1.91480000

Financial Comparison with peers

Management Efficiency

Return On Equity (%)

Return On Assets (%)

Return On Capital Employed (%)

Fixed Assets Turnover (x)

Profitability & Growth

Gross Profit Margin (%)

Operating Profit Margin (%)

Net Profit Margin (%)

Financial Strength
Liquidity

Quick Ratio (x)

Current Ratio (x)

Cash Ratio (x)

Solvency

Debt Equity Ratio (x)

Coverage Ratios

Cash Flows to Long Term Debt (x)

Peer
Average
Peer Range
Trend
16.50
8.87
-99.01
47.57
6.97
5.79
-27.48
26.25
9.68
6.57
-130.86
23.01
1.03
0.97
0.00
2.79
12.77
-8.77
-980.00
34.42
16.07
0.38
-896.19
37.94
9.37
2.06
-461.80
94.28
1.20
1.65
0.08
9.50
2.15
2.40
0.21
9.50
0.25
0.22
-0.52
1.40
0.64
0.27
0.00
1.77
3.58
3.76
0.00
45.52

Share Holding

  • Categories
    No. Of Shares
    %
  • Promoters
    131,420,046
    46.58
  • NoOfShares
    282,168,156
    100.00
  • ForeignInstitutions
    87,587,133
    31.04
  • GeneralPublic
    26,382,597
    9.35
  • Others
    15,114,522
    5.36
  • NBanksMutualFunds
    13,757,189
    4.88
  • FinancialInstitutions
    7,906,669
    2.80

Mutual Fund Ownership

Category
Rating
No. of shares
%Change in Shares
(MOM basis)
% of AUM
Amount Invested
(in ₹ Cr)
Equity: Mid Cap
5677600
0.00%
0.84%
191.51
Equity: Value Oriented
2150521
2.07%
1.59%
72.54
Hybrid: Arbitrage
559000
557.65%
0.18%
18.86
Equity: ELSS
517500
0.00%
0.23%
17.46
Hybrid: Arbitrage
382000
-7.73%
0.2%
12.88

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 9585.25 Crore) operating in Pharmaceuticals sector.

Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6042.06 Crore to Sales Value (93.93 % of Total Sales), Other Operating Revenue which contributed Rs 335.83 Crore to Sales Value (5.22 % of Total Sales) and Sale of services which contributed Rs 54.00 Crore to Sales Value (0.83 % of Total Sales)for the year ending 31-Mar-2018.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 2763.73 Crore, up 21.02 % from last quarter Sales of Rs 2283.60 Crore and up 8.81 % from last year same quarter Sales of Rs 2539.86 Crore Company has reported net profit after tax of Rs 255.54 Crore in latest quarter.

The company’s top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mr.V S Mani, Mrs.B E Saldanha, Mrs.Cherylann Pinto, Ms.Saira Ramasastry. Company has Walker, Chandiok & Co.LLP as its auditoRs As on 30-06-2019, the company has a total of 282,168,156 shares outstanding.

Loading data...
Text Size:AAA

*

Markets Data
GetET MarketsAPP